Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153634 · ClinicalTrials.gov registry record · NA
Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT00153634 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 75 participants.
The verdict
NCT00153634, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This was a randomized multi-center clinical trial to compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P. aeruginosa sputum isolates to guide antibiotic selection for treatment of airway infection in clinically stable patients with CF.
Interventions
- DRUG IV amikacin
- DRUG PO azithromycin
- DRUG IV ceftazidime
- DRUG PO ciprofloxacin
- DRUG IV meropenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00153634
The ClinicalTrials.gov registry entry for NCT00153634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which IV amikacin is the first listed.
NCT00153634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00153634 about?
NCT00153634 is a clinical study titled "Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)". This was a randomized multi-center clinical trial to compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P. aeruginosa sputum isolates to guide antibiotic selection for treatment of airway infection in clinically stable patie...
What is the current status of trial NCT00153634?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2004-03. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00153634?
The interventions under investigation include: IV amikacin (DRUG), PO azithromycin (DRUG), IV ceftazidime (DRUG), PO ciprofloxacin (DRUG), IV meropenem (DRUG).
Who is sponsoring clinical trial NCT00153634?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.